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Abstract Trypanosoma cruzi, the etiological agent of Chagas
disease, exhibits a single mitochondrion with an enlarged
portion termed kinetoplast. This unique structure harbors the
mitochondrial DNA (kDNA), composed of interlocked mole-
cules: minicircles and maxicircles. kDNA is a hallmark of
kinetoplastids and for this reason constitutes a valuable target
in chemotherapeutic and cell biology studies. In the present
work, we analyzed the effects of berenil, a minor-groove-
binding agent that acts preferentially at the kDNA, thereby
affecting cell proliferation, ultrastructure, and mitochondrial
activity of T. cruzi epimastigote form. Our results showed that
berenil promoted a reduction on parasite growth when high
concentrations were used; however, cell viability was not
affected. This compound caused significant changes in
kDNA arrangement, including the appearance of membrane
profiles in the network and electron-lucent areas in the kinet-
oplast matrix, but nuclear ultrastructure was not modified. The
use of the TdT technique, which specifically labels DNA,
conjugated to atomic force microscopy analysis indicates that
berenil prevents the minicircle decatenation of the network,
thus impairing DNA replication and culminating in the ap-
pearance of dyskinetoplastic cells. Alterations in the kineto-
plast network may be associated with kDNA lesions, as
suggested by the quantitative PCR (qPCR) technique.
Furthermore, parasites treated with berenil presented higher
levels of reactive oxygen species and a slight decrease in the
mitochondrial membrane potential and oxygen consumption.
Taken together, our results reveal that this DNA-binding drug
mainly affects kDNA topology and replication, reinforcing the
idea that the kinetoplast represents a potential target for
chemotherapy against trypanosomatids.
Keywords DNA-binding drugs . kDNA topology and
replication . Kinetoplast . Trypanosoma cruzi . Ultrastructure
Introduction
Trypanosomatids are parasites with a worldwide distribution,
and many of them are the etiological agents of endemic
diseases to human and animals. In Latin America, Chagas
disease, caused by Trypanosoma cruzi, affects approximately
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8 million people. In Africa, Trypanosoma brucei causes
sleeping sickness in humans and nagana in animals, whereas
species of the Leishmania genus cause leishmaniasis in un-
derdeveloped countries (de Souza 2002; Jensen and Englund
2012; Kennedy 2013). In this sense, intensive studies have
been performed to develop new chemotherapy compounds
and to find exclusive targets in trypanosomatid protozoa.
The Trypanosomatidae family presents remarkable fea-
tures, such as a single mitochondrion that contains an enlarged
region, termed kinetoplast, which harbors the mitochondrial
DNA (kDNA). The kDNA presents a unique network com-
posed of interlocked DNA molecules: the minicircles and
maxicircles. The minicircles encode guide RNAs that partic-
ipate in the editing of transcripts produced by the maxicircles,
which are responsible for producing rRNAs and proteins of
the respiratory chain. During the parasite cell cycle, these
circular molecules need to be replicated and then equally
segregated between daughter cells. kDNA replication begins
when topoisomerase II releases each minicircle from the net-
work to the kinetoflagellar zone (KFZ), where universal
minicircle binding protein (UMBSP) recognizes a specific
sequence of the ring that corresponds to the replication origin.
Then, primases produce the RNA primers required for initiat-
ing DNA synthesis, generating minicircles in theta intermedi-
ate forms that are reattached to the kinetoplast antipodal sites
by topo II. Finally, the primers are removed from the
minicircles by the SSE1 enzyme, and the gaps between
Okazaki fragments are filled by polymerase β. The nicks are
sealed by DNA ligase only when all minicircle replication is
completed to guarantee that this event occurs only once in the
cell cycle (reviewed by Jensen and Englund 2012).
Because the arrangement and replication of kDNA catenat-
ed circles are unique in nature, the kinetoplast may represent a
potential target for chemotherapeutic studies and also an in-
teresting structure for a better understanding of the biology of
trypanosomatid protozoa. It is also worth considering that the
mitochondrion is a symbiont-derived organelle; thus, kDNA
presents particular features, such as AT-rich regions, corre-
sponding to approximately 60 % of T. cruzi mitochondrial
DNA base pairs (Brack et al. 1972a). Such a characteristic
prompted us to investigate the effects of compounds that bind
to the DNA minor groove and have a high affinity for AT-rich
regions (Brack et al. 1972a). These compounds, termed minor
groove binders, are natural or synthetic products and include
aromatic diamidines, such as pentamidine and berenil
(diminazene aceturate) (Brack et al. 1972a; Barrett et al.
2013). Different from intercalating agents such as acriflavine,
DNA binders do not insert between two base pairs, present a
greater association with DNA, and do not require free energy
expenditure during the binding process (Palchaudhuri and
Hergenrother 2007).
Berenil has been used in the treatment of domestic
livestock trypanosomiasis and babesiosis (Peregrine and
Mamman 1993; Barrett et al. 2013). In trypanosomes, this
compound inhibits mitochondrial topoisomerase II activity
and consequently might interfere with kDNA replication
(Shapiro and Englund 1990). The specific binding of berenil
to kinetoplast DNA is also supported by the fact that there is
no detectable effect on nuclear DNA after treatment with this
compound (Macadam and Williamson 1972; Shapiro and
Englund 1990).
Several works describe the effects of berenil in T. brucei
(Egbe-Nwiyi et al. 2003; Egbe-Nwiyi et al. 2005; Witola et al.
2005) or in isolated kDNA (Brack et al. 1972a); however, the
mechanism of action of this DNA-binding compound is still
unexplored in trypanosomatids. Thus, in this work, we exam-
ined the effects of berenil on T. cruzi proliferation, mitochon-
drial activity, DNA damage, and kDNA ultrastructural orga-
nization using different approaches. Our results indicate that
the kDNA lesions promoted by berenil may induce cell
growth inhibition and kDNA rearrangement, thus resulting
in the abrogation of minicircle replication and culminating in
increases in the number of dyskinetoplastic protozoa.
Mitochondrial physiology was also affected because this or-
ganelle presented elevated amounts of reactive oxygen species




T. cruzi epimastigote forms (Y strain) were cultivated for 24 h at
28 °C in liver infusion tryptose (LIT) medium (Camargo 1964)
supplemented with 10 % fetal calf serum.
Drug treatment
Berenil was diluted in Milli-Q water at 5 mM and was added
to the culture medium after 24 h of initial growth, which
corresponds to the logarithmic phase. The drug concentrations
used in this work (2, 10, 20, and 50 μM) were determined
according to data presented in previous reports (Portugal
1994; Witola et al. 2005; Zuma et al. 2011).
Transmission electron microscopy
Routine
Parasites were washed in PBS (pH 7.2) and fixed in 2.5 %
glutaraldehyde diluted in 0.1-M cacodylate buffer (pH 7.2) at
room temperature; after 1 h, they were washed in the same
buffer. Cells were postfixed in 0.1-M cacodylate buffer con-
taining 1 % OsO4 and 0.8 % potassium ferricyanide for 1 h.
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The protozoa were then washed in the same buffer, were
dehydrated in a graded series of acetone, and embedded in
Epon (Electron Microscopy Sciences, Hatfield, PA). Ultrathin
sections were stained with uranyl acetate and lead citrate and
were observed using a Zeiss 900 transmission electron micro-
scope (Zeiss, Oberkochen, Germany).
Immunocytochemical technique—terminal deoxynucleotidyl
transferase
The terminal deoxynucleotidyl transferase (TdT) technique
was performed as described by Motta et al. (2003). For this
assay, grids containing thin sections were incubated in a
solution containing 5′-bromo-2′-deoxyuridine (BrdU), calf
thymus TdT, and dNTPs (dCTP, dGTP, and dATP). The thin
sections were then incubated with a monoclonal anti-BrdU
anti-body, washed, and incubated with goat-anti-mouse IgG
coupled to colloidal gold of 10-nm diameter. The samples
were stained as in the routine method.
kDNA isolation
kDNA networks were isolated according to the protocol de-
scribed by Pérez-Morga and Englund (1993). Nontreated and
protozoa treated with 20 and 50 μM of berenil for 48 h were
harvested by centrifugation and washed in NET 100 buffer
(i.e., 10 mM Tris-HCl [pH 8.0], 100 mM NaCl, and
100 mM EDTA). The cells were lysed at 37 °C for
60 min in a solution containing 56.5 μl of 20 % SDS
and 11 μl of proteinase K (20 mg/ml) diluted in 1 ml
of NET 100 buffer. The lysate was loaded onto a 20 %
sucrose cushion and centrifuged for 20 min at 18,000g
in an Eppendorf 5810R centrifuge. The kDNA pellet was
resuspended in NET 100, loaded on top of a second sucrose
cushion, and processed as previously described. The kDNA
was dialyzed against Tris-EDTA buffer (i.e., 10 mM Tris-HCl
[pH 8.0] and 1 mM EDTA) overnight, centrifuged at
18,000×g for 30 min, and resuspended in 1 mM Tris-HCl,
pH 8.0.
Atomic force microscopy (AFM)
The isolated kDNA networks were prepared for AFM analy-
ses as described by Cavalcanti et al. (2011). Briefly, the
solution containing the kDNA networks was mixed with
25 mMmagnesium chloride and then deposited onto a freshly
cleaved mica surface. The sample was critical point dried in a
Leica EM CPD030 apparatus according to the manufacturer’s
instructions. The network images were acquired with a
BioScope Catalyst AFM (Bruker Corporation) using the
Tapping mode in air. The AF microscope was mounted with
a high-resolution probe (nanotools® MSS-FMR-13) working
in a nominal resonant frequency of approximately 70 kHz.
The images were processed using the NanoScope analysis
software.
Fluorescence microscopy
To asses the occurrence of dyskinetoplasty, parasites were
washed in PBS, fixed in 4 % formaldehyde in PBS for
5 min, and washed. The cells were then deposited on slides
previously coated with poly-L-lysine for 10 min; the slides
were then washed. The cells were incubated with 4′,6-
diamidino-2-phenylindole (DAPI, from Molecular Probes)
diluted at 1:500 for 5 min. The slides were then washed,
mounted in N-propyl gallate, and observed using a Zeiss
Axioplan light microscope. To verify the number of
dyskinetoplastic parasites, cell counting was achieved based
on the presence of kDNA after DAPI staining.
Analysis of DNA lesions using quantitative PCR (qPCR)
assay
For this assay, cells were treated with 50 μM for up to 72 h.
Parasite cultures containing 1×107 cells/ml were harvested by
centrifugation at 3,000×g for 10 min. The supernatant (condi-
tioned medium) was saved for later use, and the cells were
resuspended in PBS. DNA extraction and quantification,
QPCR amplification, and analyses were conducted as reported
previously (Regis-da-Silva et al. 2006). The qPCR assay com-
pared the amplification of the DNA from a treated sample with
the amplification obtained with the untreated control. Specific
primers were used to amplify large and small fragments of the
nuclear and mitochondrial DNA. The large nuclear fragment
was amplified using the forward primer QPCRNuc2F (5′-
GCACACGGCTGCGAGTGACCATTCAACTTT-3′) and
the reverse primer QPCRNuc2R (5′-CCTCGCACATTTCT
ACCTTGTCCTTCAATGCCTGC-3′). The small nuclear frag-
ment was amplified with the internal primer QPCRNuc2Int (5′-
tcgagcaagctgacactcgatgcaaccaaag-3′) and the reverse primer
QPCRNuc2R. The largemitochondrial fragment was amplified
using the forward primer QPCRMitF (5′-TTTTATTTGGGG
GAGAACGGAGCG-3′) and the reverse primer QPCRMitR
(5′-TTGAAACTGCTTTCCCCAAACGCC-3′). The small
mitochondrial fragment was amplified with the internal primer
QPCRMitInt (5′-CGCTCTGCCCCCATAAAAAACCTT-3′).
Because the probability of introducing a lesion in a short
segment is very low, the small fragment (250 bp) was used to
normalize the amplification results obtained with the large
fragments (10 kb). This step eliminates the bias of changes in
the proportion between the nuclear and mitochondrial ge-
nomes. All of the primer sets were amplified in a specific
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manner, i.e., they produced only one band, as verified by gel
electrophoresis (data not show). The normalized amplification
of the treated samples was then compared with the
controls, and the relative amplification was calculated.
These values were used to estimate the average number
of lesions per 10 kb of genome through a Poisson
distribution. The final results are the mean of two sets of
qPCR results for each target gene from at least two biological
experiments.
Determination of mitochondrial membrane potential
(ΔΨm)
Protozoa were washed with PBS (pH 7.2) and then added to a
reaction medium (125 mM sucrose, 65 mM KCl, 10 mM
HEPES/K+ pH 7.2, 2 mM Pi, 1 mM MgCl2, and 500 μM
EGTA). Approximately 1×107 cells were incubated in
10 μg/ml JC-1 (a probe used to detect loss of ΔΨm), and
the absorbance was measured at every minute for 30 min
using a microplate reader (Macedo-Silva et al. 2011). We also
used 1 μM FCCP (a protonophore used to dissipate proton
gradients) as a positive control for the depolarization ofΔΨm
and 2 μM of FCCP at the end of the measurement to fully
decrease ΔΨm.
Measurement of O2 consumption
Cells were washed in PBS (pH 7.2), and 108 parasites were
incubated in a reaction medium (125 mM sucrose, 65 mM
KCl, 2 mM KH2PO4, 0.5 mM MgCl2, 10 mM HEPES pH
7.2, 1 mM EGTA, and 1 mg/ml BSA) (Silva et al. 2011).
The analysis was performed using high-resolution respi-
rometry with the OROBOROS Oxygraph-2 k. After
oxygen uptake stabilization, the cells were permeabilized
with 15 μM digitonin, and the substrates 5 mM succinate
and 200 μM ADP were added to the medium. At the end of
the experiment, 1 mM KCN was added to inhibit oxygen
consumption.
Measurement of reactive oxygen species (ROS)
production
Parasites (approximately 2.5×107) were incubated in
10 μg/ml H2DCFDA in PBS, pH 7.2, for 1 h at 28 °C.
H2DCFDA is a nonfluorescent dye that becomes fluorescent
in the presence of ROS. As a positive control for ROS
production, we used 10 μM oligomycin. The cells were
analyzed using a microplate reader, and ROS levels were
measured using the wavelengths of 507 nm as emission and
530 nm as excitation.
Cell viability
Cell viability was examined using the MTS/PMS method
(Henriques et al. 2011). In viable cells, the reagent PMS is
reduced, and the electrons are transferred to MTS, which is
converted by dehydrogenase enzymes into a water-soluble
compound, formazan, in proportion to the number of viable
cells. Parasites were incubated with MTS/PMS solution for 4 h.
As a negative control, parasites were fixed with 0.4 % formal-
dehyde for 10 min at room temperature. The cells were analyzed
using a spectrofluorometer (Molecular Devices Microplate
Reader (SpectraMax M2/M2e, Molecular Devices) at 490 nm.
Results
Berenil caused a significant reduction on T. cruzi proliferation
after treatment with 20 μM for 48 and 72 h, which is equiv-
alent to 39 and 42 %, respectively. This reduction was more
pronounced after treatment with 50 μM for 72 h, which
reached 58 % of inhibition compared to control cells.
Treatment with lower concentrations of berenil did not con-
siderably affect cell proliferation (Fig. 1). Such an effect, as
previously reported by Zuma et al. (2011), may be related to
the fact that this drug promotes remarkable modifications on
kinetoplast DNA arrangement, but does not impair cell divi-
sion. The control cells presented a typical organization, such
as a nucleus containing condensed heterochromatin, one mi-
tochondrion, a bar-shaped kinetoplast, a Golgi complex, and a
flagellum (Fig. 2a). The parasites treated with 10 μM for 72 h
presented an intense mitochondrial swelling with loss of ma-
trix, and many cells lost the typical bar-shaped kDNA. In
addition, an electron-dense round point situated in the kinet-
oplast antipodal site was observed (Fig. 2b). When the
Fig. 1 Proliferation of Trypanosoma cruzi epimastigote form after treat-
ment with berenil. The highest inhibition of parasite proliferation was
observed 50 μM for 72 h, equivalent to 58 % compared to control cells.
The asterisk indicates the addition of berenil to the culture medium. The
data are the average of three independent experiments
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parasites were treated with 20 μM for 48 h, electron-lucid
areas near the kDNA were observed, as was mitochondrial
swelling. Interestingly, some cells presented membrane pro-
files in the middle of the kDNA, which may correspond to
invaginations of the inner mitochondrial membrane (Fig. 2c).
The same effect occurred after treatment with 50 μM for 48 h,
with the membrane invaginations being more pronounced.
Despite the kinetoplast alterations, the nuclear ultrastructure
was not affected by berenil (Fig. 2d). After treatment with
50 μM for 72 h, we noted a strong kDNA network disorgani-
zation and the presence of enlarged mitochondrial cristae in
the kinetoplast (Fig. 2e, f).
The electron-lucent areas in the kinetoplast observed by
transmission electron microscopy could represent sites of
kDNA unpacking caused by the decatenation of the
maxicircles and minicircles that compose the network. To
understand this kDNA disorganization, we performed the
TdT assay, which precisely indicates the location of DNA. In
control cells, TdT labeling was observed throughout the
nuclear heterochromatin and the kinetoplast, specifically
the kDNA and KFZ region (Fig. 3a). However, in the
kinetoplast of parasites treated with 20 and 50 μM for
48 h, the gold-particle distribution was restricted to the more
condensed areas, whereas the electron-lucent sites were not
Fig. 2 Transmission electron
microscopy of T. cruzi
epimastigote treated with berenil.
a Nontreated parasites, showing
the nucleus (n), the condensed
heterochromatin (ht), the
mitochondrion (m), the
kinetoplast (k), the Golgi complex
(gc), the flagellum (f), and the
cystostome (cy). b Parasites
treated with 10 μM for 72 h. Note
the mitochondrial swelling
(asterisk) and the presence of an
electron-dense point situated in
the antipodal site (white arrow). c,
d T. cruzi treated with 20 and
50 μM for 48 h, respectively.
Cells presented mitochondrial
swelling (asterisk), electron-lucid
areas near the network (arrow),
and membrane profiles in the
middle of the kDNA
(arrowhead). Inset shows these
effects at higher magnification. e,
f Parasites treated with 50 μM for
72 h, showing electron-lucid areas
near the network (arrow),
membrane profiles (arrowhead),
and enlarged mitochondrial
cristae (star). Note that part of the




immunolabeled, indicating that this region did not contain
DNA. Interestingly, the KFZ region was not labeled, indicat-
ing the absence of free-replicating minicircles in this kineto-
plast area (Fig. 3b–d).
To better understand how berenil promotes alterations in
the kDNA arrangement, we isolated intact networks of treated
and nontreated protozoa and analyzed the samples using
AFM. In the nontreated parasites, the isolated kDNA appeared
as an intact and massive network, presenting its typical ar-
rangement with fibers homogeneously distributed throughout
the network (Fig. 4a, b). In the cells treated with 20 μM
berenil for 48 h, the organization ofmost networks was similar
to the control. However, several protozoa presented a more
compact arrangement of the kDNA in the central area of the
network (Fig. 4c, d—arrow). After treatment with 50 μM for
48 h, the effect of berenil on kDNA organization was more
intense, and condensed kDNA regions were also observed at
the periphery of the network (Fig. 4e, f—arrow).
Considering that the ultrastructural analyses showed strong
alterations in kDNA arrangement, we decided to verify the
occurrence of dyskinetoplastic protozoa (DK) in the group of
berenil-treated cells. For this purpose, the parasite morpholo-
gy and presence of kDNA were investigated using fluores-
cence microscopy. Control cells presented a typical elongated
shape of the epimastigote form, which contains a bar-shaped
kinetoplast (Fig. 5a). When the parasites were treated with
50 μM berenil for 72 h, the kinetoplast appeared smaller and
rounded (Fig. 5b). Furthermore, dividing parasites presented
atypical cellular patterns with two nuclei and a single bar-
shaped kinetoplast (Fig. 5c) or a rounded format (Fig. 5d),
indicating the formation of DK daughter cells after cytokinesis
(Fig. 5e). Such parasites are characterized by the partial or
total loss of kDNA.
Based on DAPI staining, a quantitative analysis of berenil-
treated parasites was performed to determine the percent of
dyskinetoplastic cells generated. After treatment with 50 μM
for 24 h, only 4 % of the parasites were dyskinetoplastic.
However, after 48 h of cell exposure to this DNA binder, this
percentage increased significantly to 33 and to 37% after 72 h
(Fig. 6).
Due to the striking disorganization that berenil caused in
kDNA arrangement, we performed qPCR to determine
whether there were lesions in the kinetoplast and in the
nuclear DNA. The number of kDNA lesions in the parasites
treated with 50 μM increased as the treatment proceeded,
reaching approximately 1 lesion per 10 kb of DNA after
72 h. However, no lesions were detected in the nuclear DNA
(Fig. 7), which is in accordance with the results obtained by
electron microscopy.
According to our ultrastructural analyses, the mitochondri-
on was the most altered organelle after treatment with berenil.
Thus, to investigate whether mitochondrial function was af-
fected, the membrane potential, the consumption of oxygen,
and the generation of ROS were analyzed. The results showed
that the mitochondrial membrane potential did not decrease
when the cells were exposed to 2 μM berenil for 72 h.
However, this value started to decline after treatment with
10 μM, decreasing by 20 %. After treatment with 20 and
Fig. 3 DNA localization after
treatment with berenil, using the
TdT technique. a Control cells
showing the distribution of gold
particles in the kinetoplast (k) and
the nuclear heterochromatin (ht).
Note that the KFZ region (white
arrow) is labeled by gold particles
indicating the presence of
replication minicircles. nu
nucleolus, bb basal body. b
T. cruzi treated with 20 μM for
48 h. Note that labeling was
observed in the more condensed
region of the network (k), but not
in the electron-lucent area
(asterisks). Interestingly, the KFZ
region (white arrow) is devoid of
gold particles. F flagellum. c
T. cruzi with 50 μM for 72 h. The
black arrow indicates a region




50 μM berenil, the arbitrary unit of JC1 (ΔΨm) was 33 %
lower when compared to the control parasites (Fig. 8a).
Considering the O2 consumption of intact cells, we observed
that treatment with the highest concentration (50 μM) of
berenil for 72 h slightly decreased O2 consumption in approx-
imately 17 % of the treated cells when compared to control
cells (Fig. 8b). KCN, a specific inhibitor of cytochrome oxi-
dase, was added at the end of the assays as a negative control
(Fig. 8b). Moreover, the titration of succinate and ADP slight-
ly reduced the O2 uptake rate (data not shown). ROS gener-
ation in the parasites treated with 2 and 10 μMberenil for 72 h
was very similar to the control group. However, in the para-
sites treated with 20 and 50 μM for the same period, the levels
of ROS were 2 and 3 times higher, respectively, when com-
pared to the nontreated parasites (Fig. 8c). According to the
viability test, which considered mitochondrion functioning,
most cells remained viable (90 %) even after treatment with
50 μM for 72 h (Fig. 8d), although cell proliferation was
reduced in such conditions.
Discussion
DNA-binding drugs such as berenil comprise a class of inhib-
itors that binds to the DNAminor groove leading to topological
modifications and consequently interfering with topoisomerase
activity. Because this compound presents high affinity for AT-
rich regions, it preferentially binds to kinetoplast DNA and
interferes indirectly with topoisomerase II activity (Wilson
et al. 2005). The effect of inhibitors that promote modifications
in kDNA arrangement and replication has been described,
reinforcing the idea that the kinetoplast constitutes an important
target in chemotherapeutic studies involving trypanosomatid
protozoa (Brack et al. 1972a; Portugal 1994; Liu et al. 2005).
Fig. 4 Atomic force microscopy
(AFM) of isolated kDNA
obtained from T. cruzi
epimastigotes treated with
berenil. a, b An intact network of
nontreated parasites. In b, the
enlargement permits to observe
the homogeneous distribution of
minicircles throughout the
network. c, d kDNA of T. cruzi
treated with 20 μM berenil for
48 h. The square in c was
enlarged as observed in d and
permits the observation of
condensed areas of kDNA in the
middle of the network (arrow). e,
f kDNA of T. cruzi treated with
50 μM for 48 h. It is possible to
note a complete disorganization
of the kDNA. The square in ewas
enlarged as observed in f,
revealing a more compact region




T. cruzi epimastigote proliferation was only affected when
high concentrations of berenil (20 and 50 μM) were used for
48 h of treatment; however, such conditions did not reduce
cell viability. The main effect of berenil was observed on
kinetoplast, which presented alteration on kDNA arrange-
ment; however, the nuclear ultrastructure was not modified.
In this work, a more profound structural analysis using trans-
mission electron microscopy revealed that the kDNA disor-
ganization is related to the appearance of electron-lucid areas
in the kinetoplast matrix, membrane profiles in the middle of
the network, and an electron-dense point in the antipodal site
region.
Diamidines are minor groove binders well known for their
antiparasitic potential. These compounds have been tested
successfully against T. cruzi bloodstream trypomastigotes
(de Souza et al. 2011) and against L. donovani (Wang et al.
2010), thus representing alternative drugs for trypanosomiasis
treatments. Diamidines promote ultrastructural modifications
in T. cruzi amastigotes that are similar to those described in
this work, especially mitochondrial swelling and kDNA dis-
organization (Silva et al. 2007). However, the membrane
profiles here reported in the middle of the kDNA network
were not observed in the intracellular form. Trypomastigotes
present distinct kDNA ultrastructural effects after diamidine
Fig. 5 Fluorescence optical
microscopy of T. cruzi treated
with berenil using DAPI to label
nucleus and kinetoplast. aControl
parasites showing the nucleus (n)
and the bar shape kinetoplast (k).
b–e Parasites treated with 50 μM
for 72 h. b Note that the kDNA
was rounded (arrowhead). c, d
During cytokinesis, atypical
cellular patterns were observed
containing two nuclei and a single





treatment, and this is most likely related to the looser kDNA
arrangement (Silva et al. 2007). Although the effects of
diamidines were described on parasite kDNA ultrastructure,
there are no reports about alterations in the mitochondrial
DNA of host cells.
To better understand the ultrastructural modifications after
treatment with berenil, we used the TdT technique, which
specifically labels DNA and was previously employed to study
the T. cruzi cell cycle (Elias et al. 2002). Our results showed
that the kinetoplast electron-lucent areas observed in treated
parasites were not labeled, thus indicating that this region did
not contain decatenated circles, as initially thought.
Interestingly, the KFZ region was labeled only in the control
cells, and not in the treated cells, suggesting that somehow, the
topological alterations suffered by the kDNA after berenil
treatment abrogated the release of minicircles from the net-
work. In accordance with this idea, the AFM technique showed
that berenil promoted kDNA compaction in the central and
peripheral regions of the network. Alterations in T. cruzi kDNA
organization after berenil treatment were also proposed by
Brack et al. (1972b), who reported kinetoplasts presenting
densely packed minicircles, especially in the network periph-
ery. It is also worth mentioning that detached circles were not
observed as previously reported in T. cruzi treated with acrifla-
vine, an intercalating agent (Manchester et al. 2013). Our data
obtained by AFM are also consistent with those published by
Portugal (1994) showing that berenil prevented minicircle re-
lease, thus suggesting the impairment of kDNA replication.
According to Trager and Rudzinska (1964), parasites are
considered dyskinetoplastic (DK) when Giemsa staining of
the kinetoplast is no longer detectable and the kDNA appears
altered by transmission electron microscopy. In the present
work, we suggest that the ultrastructural alterations of
kDNA promoted by berenil are related to cell growth
inhibition and minicircle replication impairment, which cul-
minate in the generation of DK parasites. The occurrence of
DK cells has been described in Leishmania tarentolae,
Crithidia fasciculata, T. brucei, T. equiperdum, and T. cruzi
treated with acriflavine (Simpson 1968; Hill and Anderson
1969; Stuart 1971; Hajduk 1979; Manchester et al. 2013).
These works also reported a size reduction of the kinetoplast
and the maintenance of the nuclear structure, as we also
observed in T. cruzi treated with berenil. It is worth discussing
that groove-binding drugs and intercalating agents most likely
cause dyskinetoplasty via different mechanisms of action: For
example, berenil prevents minicircle release from the
network, whereas acriflavine promotes minicircle detachment
(Manchester et al. 2013). However, in both cases, kDNA
replication is impaired, generating DK cells. It is worth men-
tioning that some trypanosomatid species do not present
kDNA and are naturally dyskinetoplastic. Although the typi-
cal kinetoplast is absent in these protozoa, they are viable
because their energetic metabolism does not depend exclu-
sively on mitochondrial respiration.
Nonetheless, despite all the ultrastructural alterations pro-
moted by berenil in the kinetoplast of T. cruzi, there was no
indication of cell cycle arrest. This suggests that the preven-
tion of mitochondrial DNA replication was not able to pro-
mote cell cycle blockade, as observed when nuclear DNA is
affected by camptothecin, a topoisomerase I inhibitor that
promotes heterochromatin unpacking (Zuma et al. 2014).
In agreement with microscopy analyses, our qPCR assays
showed that berenil caused damage to the kDNA, but not the
nuclear DNA, which can be affected after treatment with
camptothecin (Zuma et al. 2014). These data reinforce the idea
that the kinetoplast is the main target of berenil (Macadam and
Williamson 1972; Shapiro and Englund 1990). In fact, the
mitochondrion as a whole was the most affected organelle in
Fig. 7 Quantitative qPCR-basedmeasurement of berenil-induced lesions
after treatment with 50 μM up to 72 h. Detection of one lesion per 10 kb
of DNAwas observed in the mitochondrial DNA. In the nuclear DNA, no
lesions were detected
Fig. 6 Quantification of dyskinetoplastic (DK) parasites after treatment
with berenil. The percentage of DK cells significantly increased after 48 h
of treatment and reached 37 % after 72 h
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T. cruzi after berenil treatment, as revealed by different meth-
odologies that assessed mitochondrial physiology. An evalua-
tion of the membrane potential (ΔΨm) clearly showed that the
cells treated with 10 μM for 72 h have an altered ion concen-
tration gradient between the matrix and intermembrane space,
which resulted in a decrease in ΔΨm compared to the control
cells. Protozoa treatment with 20 and 50 μM of berenil was
more drastic, because the decrease inΔΨm started immediate-
ly after addition of the drug. Alterations in the mitochondrial
membrane potential are directly related to the production of
ROS (Korshunov et al. 1997). In this sense, the berenil-treated
protozoa presented increased ROS generation, which duplicat-
ed or triplicated after exposure to 20 or 50 μM of the drug,
respectively, for 72 h when compared to the control cells. It is
noteworthy that ROS production was enhanced as the treat-
ment proceeded from 24 to 72 h using different drug concen-
trations, especially 20 and 50 μM (Online Resource 1).
As previously reported, the production of ROS may be
related to lesions in mitochondrial and nuclear DNA (Storr
et al. 2013). Thus, we can suggest that the lesions detected in
T. cruzi kDNA by qPCR after treatment with berenil may have
been caused by ROS and are not only a result of the ultra-
structural alterations promoted by this DNA-binding drug. In
addition, O2 consumption was slightly reduced after berenil
treatment. These data indicate that berenil induced mitochon-
drial ROS generation in addition to causing changes in mito-
chondrial functioning; however, the specific mechanism of
alteration in the imbalance of ROS metabolism deserves
further investigation. Because these assays were performed
in the presence of KCN, our data indicate that most of the O2
uptake was associated with oxidative phosphorylation and not
an alternative oxidase enzyme. It is important to note that
despite all these important alterations in mitochondrial phys-
iology, the O2 consumption slightly decayed indicating that
the organelle functioning was preserved, permitting that treat-
ed parasites remained viable even after 72 h of treatment.
Taking together all the data obtained in the present work,
we can propose the berenil mechanism of action in the T. cruzi
epimastigote form. This minor groove binder selectively tar-
gets the kinetoplast and promotes drastic ultrastructural
changes in kDNA, which prevents minicircle release from
the network and its replication. This reduces parasite prolifer-
ation but does not affect its viability, thus enabling cell divi-
sion and generation of DK cells. Berenil may also promote
lesions in kDNA and affect mitochondrial physiology.
Because the kinetoplast is unique in nature for presenting a
DNA organization and replication completely different from
that observed in the mitochondria of other organisms, this
structure represents a promising target in the development of
new compounds against pathogenic trypanosomatids.
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